First Time Loading...
L

Lucira Health Inc
NASDAQ:LHDX

Watchlist Manager
Lucira Health Inc
NASDAQ:LHDX
Watchlist
Price: 0.0339 USD -19.29% Market Closed
Updated: May 6, 2024

Lucira Health Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Lucira Health Inc
Research & Development Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
L
Lucira Health Inc
NASDAQ:LHDX
Research & Development
-$39.8m
CAGR 3-Years
-71%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Research & Development
-$1.2B
CAGR 3-Years
-5%
CAGR 5-Years
-3%
CAGR 10-Years
-9%
Boston Scientific Corp
NYSE:BSX
Research & Development
-$1.4B
CAGR 3-Years
-9%
CAGR 5-Years
-5%
CAGR 10-Years
-5%
Stryker Corp
NYSE:SYK
Research & Development
-$1.3B
CAGR 3-Years
-10%
CAGR 5-Years
-9%
CAGR 10-Years
-9%
Abbott Laboratories
NYSE:ABT
Research & Development
-$2.6B
CAGR 3-Years
-2%
CAGR 5-Years
-2%
CAGR 10-Years
-7%
Intuitive Surgical Inc
NASDAQ:ISRG
Research & Development
-$1B
CAGR 3-Years
-20%
CAGR 5-Years
-17%
CAGR 10-Years
-20%

See Also

What is Lucira Health Inc's Research & Development?
Research & Development
-39.8m USD

Based on the financial report for Dec 31, 2021, Lucira Health Inc's Research & Development amounts to -39.8m USD.

What is Lucira Health Inc's Research & Development growth rate?
Research & Development CAGR 3Y
-71%

Over the last year, the Research & Development growth was -62%. The average annual Research & Development growth rates for Lucira Health Inc have been -71% over the past three years .